Compare ARK Genomic Revolution ETF (ARKG) vs MPLX LP (MPLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs MPLX LP — how do they compare? ARK Genomic Revolution ETF trades at $40.51, while MPLX LP trades at $57.27 (market cap $57.79B). The key difference: MPLX LP pays a 7.56% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | MPLX | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $59.17 |
52-Week Low | $23.09 | $47.80 |
Market Cap | — | $57.79B |
Enterprise Value | — | $82.42B |
Dividend Yield | — | 7.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About MPLX LP
MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.
Read more on MPLX →
